Information about Homocysteine

Chemical structure of Homocysteine
Homocysteine
Systematic (IUPAC) name
(2S)-2-amino-4-sulfanyl-butanoic acid
Identifiers
CAS number	454-29-5
PubChem	91552
Chemical data
Formula	C4H9NO2S
Mol. weight	135.186
SMILES	C(CS)C(C(=O)O)N
Complete data

Homocysteine is a chemical compound with the formula HSCH₂CH₂CH(NH₂)CO₂H. It is a homologue of the naturally-occurring amino acid cysteine, differing in that its side-chain contains an additional methylene (-CH₂-) group before the thiol (-SH) group. Alternatively, homocysteine can be derived from methionine by removing the latter's terminal C^ε methyl group.

Organic chemical properties

The "extra" (relative to cysteine) one carbon methylene group allows this molecule to form a five-membered ring, homocysteine thiolactone. The facility of this reaction precludes the formation of stable peptide bonds. In other words, a protein containing homocysteine would tend to cleave itself.

The 4 carbon homocysteine is (only) made from the 5 carbon methionine, an essential amino acid, in a multi step reaction via S-adenosyl methionine. Homocysteine can be recycled back into methionine or it can be permanently converted to cysteine via the transsulfuration pathway. Homocysteine is not obtained from the diet; it is a normal temporary and chemically reactive reaction product that can be measured in blood.^[1] Due to its high reactivity to proteins, it is almost always bound to proteins, 'thiolating' (and thus degrading) most notably the lysine and cysteine components thereof. This can permanently affect protein function. In blood, it is found bound to albumin and to hemoglobin. It affects enzymes with cysteine-containing active sites, for example, it inhibits lysyl oxidase a key enzyme in the production of collagen and elastin, two main structural proteins in artery, bone and skin.

Elevated homocysteine

As a consequence of the biochemical reactions in which homocysteine is involved, deficiencies of the vitamins folic acid (B₉), pyridoxine (B₆), or B₁₂ (cyanocobalamin) can lead to high homocysteine levels.^[2] Supplementation with pyridoxine, folic acid, B₁₂ or trimethylglycine (betaine) reduces the concentration of homocysteine in the bloodstream.^{[3] [4]} Increased levels of homocysteine are linked to high concentrations of endothelial asymmetric dimethylarginine.

Elevations of homocysteine also occur in the rare hereditary disease homocystinuria and in the methylene-tetrahydrofolate-reductase polymorphism genetic traits. The latter is quite common (about 10% of the world population) and it is linked to an increased incidence of thrombosis and cardiovascular disease and that occurs more often in people with above minimal levels of homocysteine (about 6 μmol/L). Common levels in Western populations are 10 to 12 and levels of 20 μmol/L are found in populations with low B-vitamin intakes (New Delhi) or in the older elderly (Rotterdam, Framingham). Women have 10-15% less homocysteine during their reproductive decades than men which may help explain the fact they suffer myocardial infarction (heart attacks) on average 10 to 15 years later than men.

Cardiovascular risks

A high level of blood serum homocysteine is a powerful risk factor for cardiovascular disease. Unfortunately attempts to decrease the risk by lowering homocysteine have not been fruitful.^[5]

Studies reported in 2006 have shown that giving vitamins [folic acid, B6 and B12] to reduce homocysteine levels may not quickly offer benefit, however a significant 25% reduction in stroke was found in the HOPE-2 study ^[6] even in patients mostly with existing serious arterial decline although the overall death rate was not significantly changed by the intervention in the trial. Clearly, reducing homocysteine does not quickly repair existing structural damage of the artery architecture. However, the science is strong supporting the biochemistry that homocysteine degrades and inhibits the formation of the three main structural components of the artery, collagen, elastin and the proteoglycans. Homocysteine permanently degrades cysteine [disulfide bridges] and lysine amino acid residues in proteins, gradually affecting function and structure. Simply put, homocysteine is a 'corrosive' of long-living [collagen, elastin] or life-long proteins [fibrillin]. These long-term effects are difficult to establish in clinical trials focusing on groups with existing artery decline. The main role of reducing homocysteine is likely in 'prevention' but with a slow but probable role in 'cure'. ^[6][7][8]

Bone weakness

Elevated levels of homocysteine have been linked to increased fractures in elderly persons.^[9][10] Homocysteine does not appear to have any effect on bone density. Instead, it appears that homocysteine affects collagen by interfering with the cross-linking between collagen fibers and the tissues they reinforce.

Vitamin supplements could counter the effects of homocysteine on collagen. As B₁₂ is inefficiently absorbed from food by elderly persons, they could gain a greater benefit from taking in higher doses orally or via intramuscular injection.

References

• Methionine and Homocysteine
• Structure, Properties, and metabolism of Homocysteine

• How homocysteine degrades (thiolates) proteins in arteries.

External links

• Homocysteine information site